- Home
- ALEC vs GCMG Comparison
ALEC vs GCMG Comparison
Compare ALEC & GCMG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALEC
- GCMG
- Stock Information
- Founded
- ALEC 2013
- GCMG 1971
- Country
- ALEC United States
- GCMG United States
- Employees
- ALEC N/A
- GCMG N/A
- Industry
- ALEC Biotechnology: Biological Products (No Diagnostic Substances)
- GCMG Finance/Investors Services
- Sector
- ALEC Health Care
- GCMG Finance
- Exchange
- ALEC Nasdaq
- GCMG Nasdaq
- Market Cap
- ALEC 487.7M
- GCMG 484.5M
- IPO Year
- ALEC 2019
- GCMG N/A
- Fundamental
- Price
- ALEC $5.15
- GCMG $11.47
- Analyst Decision
- ALEC Strong Buy
- GCMG Buy
- Analyst Count
- ALEC 6
- GCMG 5
- Target Price
- ALEC $17.75
- GCMG $12.60
- AVG Volume (30 Days)
- ALEC 535.7K
- GCMG 149.5K
- Earning Date
- ALEC 11-05-2024
- GCMG 11-06-2024
- Dividend Yield
- ALEC N/A
- GCMG 3.83%
- EPS Growth
- ALEC N/A
- GCMG N/A
- EPS
- ALEC N/A
- GCMG N/A
- Revenue
- ALEC $55,275,000.00
- GCMG $461,325,000.00
- Revenue This Year
- ALEC N/A
- GCMG $15.21
- Revenue Next Year
- ALEC $96.01
- GCMG $13.73
- P/E Ratio
- ALEC N/A
- GCMG $31.99
- Revenue Growth
- ALEC N/A
- GCMG 4.14
- 52 Week Low
- ALEC $3.66
- GCMG $7.70
- 52 Week High
- ALEC $8.90
- GCMG $11.77
- Technical
- Relative Strength Index (RSI)
- ALEC 53.11
- GCMG 58.46
- Support Level
- ALEC $4.20
- GCMG $11.02
- Resistance Level
- ALEC $5.35
- GCMG $11.77
- Average True Range (ATR)
- ALEC 0.33
- GCMG 0.20
- MACD
- ALEC 0.07
- GCMG -0.01
- Stochastic Oscillator
- ALEC 82.68
- GCMG 60.00
About ALEC Alector Inc.
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.
About GCMG GCM Grosvenor Inc.
GCM Grosvenor Inc is a world-wide alternative asset management firm. It invests on behalf of clients who seek allocations to alternative investments, such as private equity, infrastructure, real estate, credit, ESG and absolute return strategies. The company's offerings include multi-manager portfolios as well as portfolios of direct investments and co-investments.